Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints by Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, Scott L. Friedman

Get full text

Resolvin D1-mediated cellular crosstalk protects against MASH by Amaia Navarro-Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Bruno Cogliati, Jerry E. Chipuk, Oren Rom, Scott L. Friedman, Brian E. Sansbury, Xin Huang, Bishuang Cai

Get full text

SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis by Varinder S Athwal, James Pritchett, Jessica Llewellyn, Katherine Martin, Elizabeth Camacho, Sayyid MA Raza, Alexander Phythian‐Adams, Lindsay J Birchall, Aoibheann F Mullan, Kim Su, Laurence Pearmain, Grace Dolman, Abed M Zaitoun, Scott L Friedman, Andrew MacDonald, William L Irving, Indra N Guha, Neil A Hanley, Karen Piper Hanley

Get full text

The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination. by Benjamin M Laitman, Linnéa Asp, John N Mariani, Jingya Zhang, Jia Liu, Setsu Sawai, Candice Chapouly, Sam Horng, Elisabeth G Kramer, Nesanet Mitiku, Hannah Loo, Natalie Burlant, Xiomara Pedre, Yuko Hara, German Nudelman, Elena Zaslavsky, Young-Min Lee, David A Braun, Q Richard Lu, Goutham Narla, Cedric S Raine, Scott L Friedman, Patrizia Casaccia, Gareth R John

Get full text